首页> 外文期刊>The Foot >Effects of hot foot and arm bath in bronchial asthma: A single case report
【24h】

Effects of hot foot and arm bath in bronchial asthma: A single case report

机译:热脚和臂浴在支气管哮喘中的影响:单一案例报告

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Managing the condition of corticosteroid resistant asthmatic patients is quite difficult and challenging despite the plethora of new and modern medications. Hot Foot and Arm Bath (HFAB) is a widely used treatment modality for the management of bronchial asthma in Naturopathy. However, no scientific documentation or study is available so far assessing its effectiveness. Case summary: A 33-year-old male was admitted to our hospital, with major complaints of wheezing and dyspnea for two weeks before admission, with a known case of asthma and occasional use of inhalers. Spirometry tests showed a reversible obstructive pattern (pre-bronchodilator FEV1, 1.64 L; post-bronchodilator FEV1, 2.02 L; reversibility, 16%). The patient underwent HFAB application for 3 days in the morning, and the pulmonary function test was recorded before and immediately after HFAB. The pulmonary function's parameters such as FVC, FEV1, FEV1/FVC ratio, PEF 25-75 %, and PEFR showed significant improvement immediately after the HFAB on day 2 and day 3 when compared to day 1. Conclusions: The findings suggest that HFAB application has an immediate action on improving lung function in patients with bronchial asthma and could be used as effective adjuvant therapy for the management of bronchial asthma. This is the first case report on HFAB application for bronchial asthma and future extensive studies with a large population would validate our findings.
机译:背景:尽管有过多的新的和现代的药物,但对糖皮质激素抵抗的哮喘患者的状况进行管理是相当困难和具有挑战性的。热脚和手臂浴(HFAB)是自然疗法中治疗支气管哮喘的一种广泛使用的治疗方式。然而,到目前为止,还没有评估其有效性的科学文献或研究。病例总结:一名33岁男性入院,入院前两周主要症状为喘息和呼吸困难,已知病例为哮喘,偶尔使用吸入器。肺活量测定显示可逆性阻塞模式(支气管扩张剂前FEV1,1.64升;支气管扩张剂后FEV1,2.02升;可逆性,16%)。患者在早上接受HFAB应用3天,并在HFAB之前和之后立即记录肺功能测试。与第1天相比,HFAB后第2天和第3天的肺功能参数,如FVC、FEV1、FEV1/FVC比率、PEF 25-75%和PEFR,立即显示出显著改善。结论:研究结果表明,应用HFAB可立即改善支气管哮喘患者的肺功能,并可作为支气管哮喘治疗的有效辅助疗法。这是HFAB应用于支气管哮喘的第一例病例报告,未来大规模人群的广泛研究将验证我们的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号